Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
CC transcript

IONIS PHARMACEUTICALS INC (IONS) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 144 Form 144 - Report of proposed sale of securities:
10/12/2023 144/A Form 144/A - Report of proposed sale of securities: [Amend]
09/29/2023 4 BENNETT C FRANK (EVP, Chief Scientific Officer) has filed a Form 4 on IONIS PHARMACEUTICALS INC
Txns: Sold 4,460 shares @ $46.5, valued at $207.4k
09/29/2023 144 Form 144 - Report of proposed sale of securities:
09/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/27/2023 8-K Quarterly results
09/26/2023 144 Form 144 - Report of proposed sale of securities:
09/26/2023 144 Form 144 - Report of proposed sale of securities:
08/23/2023 8-K Other Events  Interactive Data
08/14/2023 144/A Form 144/A - Report of proposed sale of securities: [Amend]
08/10/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/09/2023 8-K Quarterly results
Docs: "CARLSBAD, Calif., August 9, 2023"
08/04/2023 8-K Termination of a Material Definitive Agreement  Interactive Data
08/03/2023 4 Diaz Allene M. (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC
Txns: Sold 657 shares @ $41.05, valued at $27k
08/03/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "CARLSBAD, Calif., –"
08/02/2023 144 Form 144 - Report of proposed sale of securities:
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2023 144 Form 144 - Report of proposed sale of securities:
07/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/10/2023 8-K Quarterly results
07/07/2023 144 Form 144 - Report of proposed sale of securities:
07/06/2023 4 WENDER JOSEPH H (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC
Txns: Granted 10,321 options to buy @ $41.08, valued at $424k
Granted 4,677 restricted stock units @ $0
07/06/2023 4 PARSHALL B LYNNE (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC
Txns: Granted 10,321 options to buy @ $41.08, valued at $424k
Granted 4,677 restricted stock units @ $0
07/06/2023 4 LOSCALZO JOSEPH (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC
Txns: Granted 10,321 options to buy @ $41.08, valued at $424k
Granted 4,677 restricted stock units @ $0
07/06/2023 4 KLEIN JOSEPH III (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC
Txns: Granted 10,321 options to buy @ $41.08, valued at $424k
Granted 4,677 restricted stock units @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy